| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/21/2010 | EP1250328B2 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/21/2010 | EP0888303B1 Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains |
| 04/21/2010 | CN1923820B Novel carboxylic acid derivatives, their preparation and use |
| 04/21/2010 | CN1854134B Piperazine compounds, their preparation method and pharmaceutical composition containing same |
| 04/21/2010 | CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/21/2010 | CN1522246B Triamide-substituted indoles, benzofuranes and benzothiophenes |
| 04/21/2010 | CN101696192A Pyrimidine substituted acrylic ester compounds with fungicidal activities and preparation method thereof |
| 04/20/2010 | USRE41252 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 04/20/2010 | US7700794 Fluorous tagging compounds and methods of increasing the fluorous nature of compounds |
| 04/20/2010 | US7700784 angiotension II receptor antagonists or AT1 receptor antagonists |
| 04/20/2010 | US7700772 Amino heterocyclic modulators of chemokine receptor activity |
| 04/20/2010 | US7700771 antiinflammatory agents; antiarthritic agents |
| 04/20/2010 | US7700770 recrystallizing from a polar aprotic solvent (dimethylsulfoxide, dimethylformamide, dimethylacetamide, or N-methylpyrrolidinone) and a cosolvent (acetonitrile, ethanol, methylethyl ketone, isopropyl alcohol, or 1-propanol); myelodysplastic syndrome |
| 04/20/2010 | US7700638 Such as 7-(3-Chlorophenyl)-1-phenyl-5-trifluoromethylbenzimidazole; antianxiety agents; side effect reduction |
| 04/20/2010 | US7700632 3-(3-Chloro-biphenyl-4-yloxymethyl)-benzoic acid; antidiabetic; type 2 diabetes, insulin resistance, impaired glucose tolerance, obesity |
| 04/20/2010 | US7700631 Use of pyridine N-oxide analogs at doses which do not induce emesis |
| 04/20/2010 | US7700630 3-Quinolin-2-ylmethylene-3,4,5,6-terahydro[2,3']bipyridinyl; for therapy and prophylaxis of psychotic diseases, neurodegenerative diseases involving a dysfunction of the cholinergic system |
| 04/20/2010 | US7700621 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 04/20/2010 | US7700602 And beta-amyloid formation; Alzheimer's Disease; 2-amino-5-(4-fluoro-3-pyrimidin-5-ylphenyl)-5-(4-methoxy-3-methylphenyl)-3-methyl-3,5-dihydro-4H-imidazol-4-one |
| 04/20/2010 | CA2510540C Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 04/20/2010 | CA2494067C Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 04/15/2010 | WO2010042939A1 Preparation of alicyclic diepoxides |
| 04/15/2010 | WO2010042674A1 Pyrrolone melanin concentrating hormone receptor-1 antagonists |
| 04/15/2010 | WO2010042489A2 Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use |
| 04/15/2010 | WO2010042473A1 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 04/15/2010 | WO2010040826A1 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors |
| 04/15/2010 | WO2010040663A1 Pyrrolidine n-benzyl derivatives |
| 04/15/2010 | WO2009024341A8 Condensed anthran i lami de derivatives as insectisides |
| 04/15/2010 | US20100094041 Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analogues |
| 04/15/2010 | US20100093825 Bicycloester derivative |
| 04/15/2010 | US20100093817 Compounds |
| 04/15/2010 | US20100093806 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |
| 04/15/2010 | US20100093802 Ccr9 inhibitors and methods of use thereof |
| 04/15/2010 | US20100093737 Nucleoside and Nucleotide Analogues with Quaternary Carbon Centers and Methods of Use |
| 04/15/2010 | US20100093702 METHYLENE AMINES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 04/15/2010 | US20100093694 Compounds for the Treatment of Hepatitis C |
| 04/15/2010 | US20100093693 Modulators of cellular adhesion |
| 04/15/2010 | US20100092541 Compositions and methods for treatment of eye disorders |
| 04/15/2010 | CA2738870A1 Pyrrolidine n-benzyl derivatives |
| 04/14/2010 | EP2174936A1 PNA monomer and precursor |
| 04/14/2010 | EP2173741A1 A process for the preparation of olmesartan medoxomil |
| 04/14/2010 | EP2173722A2 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
| 04/14/2010 | EP2173720A2 2-imidazolines having a good affinity to the trace amine associated receptors (taars) |
| 04/14/2010 | EP2173713A2 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/14/2010 | EP2173354A1 Quinoxaline derivatives as pi3 kinase inhibitors |
| 04/14/2010 | EP2173350A2 Stereoselective process for preparing purine dioxolane nucleoside derivatives |
| 04/14/2010 | EP2173346A2 Use of compounds for preparing anti-tuberculosis agents |
| 04/14/2010 | EP1919869B1 Indole derivatives as ppar activators |
| 04/14/2010 | EP1858890B1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments |
| 04/14/2010 | EP1537078B1 Indoles having anti-diabetic activity |
| 04/14/2010 | EP1477482B1 Novel phenylalanine derivative |
| 04/14/2010 | CN101693708A Azasugar compound containing aryl and preparation process and application thereof |
| 04/14/2010 | CN101693697A Pyrizdazine derivatives and their use as therapeutic agents |
| 04/14/2010 | CN101693695A Pyrimidine derivatives and methods of treatment related to the use thereof |
| 04/13/2010 | US7696365 Heterocyclic compounds useful as malonyl-CoA decarboxylase inhibitors |
| 04/13/2010 | US7696357 Darifenacin solvate with toluene; mixing the free base with toluene to form the solvate, converting to the hydrate, addition salt formation with hydrogen bromide; high purity, extended shelf life; irritable bowel syndrome, incontinence and other gastrointestinal disorders |
| 04/13/2010 | US7696257 Oxime ester compound and photopolymerization initiator containing such compound |
| 04/13/2010 | US7696246 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 04/13/2010 | US7696245 Pyridylalkyl-amino-substituted spiro(phthalan-1,9'-xanthene) or xanthene compounds that complex zinc; can measure zinc ions with high sensitivity without damaging cells; can measure fluorescence with a long wavelength excitation light |
| 04/13/2010 | US7696231 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 04/13/2010 | US7696226 HIV protease inhibiting compounds |
| 04/13/2010 | US7696216 Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives |
| 04/13/2010 | US7696214 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 04/13/2010 | US7696205 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; 4-Methylsulfanyl-N-{2-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-acetylamino]-cyclohexyl}-benzamide |
| 04/13/2010 | US7696204 Pharmaceutical compounds |
| 04/13/2010 | US7696198 Phosphodiesterase 4 inhibitors |
| 04/13/2010 | US7696195 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
| 04/13/2010 | US7696193 Such as 6-(3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-N-methyl-nicotinamide; for treatment of neurological and psychiatric disorders |
| 04/13/2010 | CA2432303C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2422377C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2295678C Pyridine derivatives |
| 04/09/2010 | CA2737349A1 Indazole derivatives |
| 04/08/2010 | WO2010039793A1 Hepatitis c virus inhibitors |
| 04/08/2010 | WO2010039534A2 Viral and fungal inhibitors |
| 04/08/2010 | WO2010039256A1 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 04/08/2010 | WO2010038803A1 2-indoleacrylamide analogue |
| 04/08/2010 | WO2010038465A1 8-substituted isoquinoline derivative and use thereof |
| 04/08/2010 | WO2010038167A1 Oxopiperidinyl and pyranyl sulfonamides as ampa potentiators |
| 04/08/2010 | WO2010038081A2 Heterocyclic derivatives and methods of use thereof |
| 04/08/2010 | WO2010037210A1 Viral polymerase inhibitors |
| 04/08/2010 | WO2010037190A1 Compounds derived from 2-(3-methylenedioxy)-benzoyl indol |
| 04/08/2010 | WO2010018231A3 Salt of, and processes for the preparation of, 1-isopropyl-4-{[4-(tetrahydro-2h-pyran- 4-yloxy)phenyl]carbonyl}hexahydro-1h-1,4-diazepine |
| 04/08/2010 | US20100087622 Method of Synthesizing Acetonide-Protected Catechol-Containing Compounds and Intermediates Produced Therein |
| 04/08/2010 | US20100087490 Dosage Units of 3-(6-(1-(2,2-Difluorobenzo[D] [1,3] Dioxol-5-YL) Cyclopropanecarboxamido)-3-Methylpyridin-2-YL)Benzoic Acid |
| 04/08/2010 | US20100087487 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| 04/08/2010 | US20100087483 Aminosulfonyl Substituted 4-(Aminomethyl)-Piperidine Benzamides As 5HT 4-Antagonists |
| 04/08/2010 | US20100087479 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |
| 04/08/2010 | US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/08/2010 | US20100087432 Pyrrole derivatives having crth2 receptor antagonist activity |
| 04/08/2010 | US20100087427 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 04/08/2010 | US20100087320 Arylphenyl-substituted cyclic keto-enols |
| 04/08/2010 | CA2738768A1 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 04/08/2010 | CA2738694A1 Compounds derived from 2-(3-methylenedioxy)-benzoyl indol |
| 04/08/2010 | CA2738563A1 8-substituted isoquinoline derivatives and the use thereof |
| 04/08/2010 | CA2738313A1 Viral and fungal inhibitors |
| 04/08/2010 | CA2738041A1 Oxopiperidinyl and pyranyl sulfonamides as ampa potentiators |
| 04/07/2010 | EP2172460A1 Compositions useful as inhibitors of JAK and other protein kinases |
| 04/07/2010 | EP2172458A1 Pyrazolone derivative |
| 04/07/2010 | EP2172457A2 Fredericamycin derivatives |
| 04/07/2010 | EP2172443A1 Method for producing optically active amine |